| P50 | author | Sundeep Khosla | Q42164143 |
| P2093 | author name string | Bart L Clarke | |
| P2860 | cites work | Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue | Q24679625 |
| | Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 |
| | The Impact of Gonadal Steroid Hormone Action on Growth Hormone Secretion During Childhood and Adolescence* | Q30438131 |
| | Sex steroids and bone | Q31817124 |
| | Localization of estrogen receptor beta protein expression in adult human bone. | Q32006661 |
| | Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden | Q33239089 |
| | The effects of testosterone on osteoporosis in men. | Q33723618 |
| | Steroid hormone receptor expression and action in bone | Q33829036 |
| | Identification of androgen receptors in normal human osteoblast-like cells | Q33834413 |
| | Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist | Q33858495 |
| | Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels | Q33943952 |
| | The effects of oestrogens on linear bone growth | Q33949996 |
| | DHEA in elderly women and DHEA or testosterone in elderly men. | Q34000294 |
| | Clinical Review 116: Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone | Q34075696 |
| | Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone | Q34131306 |
| | Sex steroids and the construction and conservation of the adult skeleton | Q34131889 |
| | Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor | Q34224435 |
| | Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites | Q34366766 |
| | Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. | Q34415758 |
| | Altered bone mineral density in patients with complete androgen insensitivity syndrome. | Q34492145 |
| | Clinical review 144: Estrogen and the male skeleton | Q34587203 |
| | Transcriptional up-regulation of the human androgen receptor by androgen in bone cells | Q34740453 |
| | Androgens regulate bone resorption activity of isolated osteoclasts in vitro | Q34818200 |
| | Osteoporosis during androgen deprivation therapy for prostate cancer | Q34856701 |
| | Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study | Q36465030 |
| | Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty | Q36805507 |
| | Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men | Q37272054 |
| | Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells | Q38324907 |
| | Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. | Q40134234 |
| | Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. | Q40713758 |
| | Determinants of bone density in healthy older men with low testosterone levels | Q40747297 |
| | Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor | Q40784699 |
| | Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness | Q40945365 |
| | Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line | Q41009217 |
| | Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study | Q41714023 |
| | Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. | Q41756245 |
| | Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors | Q42639872 |
| | Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution. | Q43576962 |
| | Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists | Q43633903 |
| | The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. | Q43633936 |
| | Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. | Q43650554 |
| | A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency | Q43732380 |
| | Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer | Q43749401 |
| | Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. | Q43791669 |
| | Pathogenesis of vertebral crush fractures in men | Q43982053 |
| | Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. | Q44238589 |
| | Differential effects of androgens and estrogens on bone turnover in normal men. | Q44273273 |
| | Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein | Q44345535 |
| | Androgens directly stimulate proliferation of bone cells in vitro | Q44363251 |
| | A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women | Q44709949 |
| | Sex hormones mediate interleukin-1β production by human osteoblastic HOBIT cells | Q45082467 |
| | Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study. | Q46080336 |
| | Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells | Q46259138 |
| | Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study | Q46270750 |
| | Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? | Q46492115 |
| | Effect of testosterone treatment on bone mineral density in men over 65 years of age. | Q48759951 |
| | Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. | Q50623955 |
| | Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. | Q50877209 |
| | Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. | Q50915518 |
| | Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. | Q50921556 |
| | Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. | Q50941992 |
| | Androgen-receptor blockade does not impair bone mineral density in adolescent females. | Q50950580 |
| | Estrogen, progesterone and testosterone receptors in human fetal cartilaginous tissue: immunohistochemical studies. | Q50954072 |
| | Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. | Q51044416 |
| | Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. | Q51629207 |
| | Direct administration of testosterone increases rat tibial epiphyseal growth plate width. | Q52244989 |
| | Effects of testosterone replacement in hypogonadal men. | Q52970270 |
| | Finasteride therapy does not alter bone turnover in men with benign prostatic hyperplasia--a Clinical Research Center study. | Q53811664 |
| | Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. | Q54104714 |
| | Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist1 | Q56429446 |
| | Androgens and Bone | Q57606357 |
| | Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male | Q58086773 |
| | Demonstration of Estrogen Receptor-β Immunoreactivity in Human Growth Plate Cartilage | Q61480392 |
| | Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolism | Q67467248 |
| | Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae | Q68648059 |
| | Biological effects of androgens and identification of specific dihydrotestosterone-binding sites in cultured human fetal epiphyseal chondrocytes | Q68690362 |
| | Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation | Q69636878 |
| | Effect of excess endogenous androgens on bone density in young women | Q70063539 |
| | High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement | Q71091887 |
| | Testosterone therapy in glucocorticoid-treated men | Q71098016 |
| | Risk factors for spinal osteoporosis in men | Q71123827 |
| | A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty | Q71441877 |
| | Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism | Q71857797 |
| | Androgens and bone | Q71916439 |
| | Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells | Q72132570 |
| | Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrhoeic women with androgen excess | Q72346200 |
| | Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro | Q73168558 |
| | Effects of DHEA replacement on bone mineral density and body composition in elderly women and men | Q73270915 |
| | The localization of androgen receptors in human bone | Q73785087 |
| | Estrogen receptors alpha and beta are differentially expressed in developing human bone | Q73853603 |
| | Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men | Q74166335 |
| | Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat | Q74252553 |
| | Sex steroid metabolism in the tibial growth plate of the rat | Q74805683 |
| | Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome | Q77519218 |
| | Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty | Q77676740 |
| P433 | issue | 3 | |
| P304 | page(s) | 296-305 | |
| P577 | publication date | 2008-10-17 | |
| P1433 | published in | Steroids | Q15716675 |
| P1476 | title | Androgens and bone | |
| P478 | volume | 74 | |